Healthcare 3D Printing Market Analysis, By Application, By Technology, By Raw Material And Segment Forecast From 2012 To 2020

Table of Contents

Chapter 1. Executive Summary
1.1. Healthcare 3D printing - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Healthcare 3D Printing Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Healthcare 3D Printing Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Healthcare 3D Printing - Company Market Share Analysis
2.7. Healthcare 3D Printing Market PESTEL Analysis, 2012

Chapter 3. Healthcare 3D Printing Application Outlook
3.1. Surgical Guides
3.1.1.Surgical Guides Market Estimates and Forecasts, 2012 - 2020 (USD Million)
3.1.2.Orthopedic Surgical Guides Market Estimates and Forecasts, 2012 - 2020 (USD Million)
3.1.3.Crani-maxillofacial Surgical Guides Market Estimates and Forecasts, 2012 - 2020 (USD Million)
3.1.4.Dental Surgical Guides Market Estimates and Forecasts, 2012 - 2020 (USD Million)
3.2. Implants
3.2.1.Implants Market Estimates and Forecasts, 2012 - 2020 (USD Million)
3.2.2.Orthopedic Implants Market Estimates and Forecasts, 2012 - 2020 (USD Million)
3.2.3.Crani-maxillofacial Implants Market Estimates and Forecasts, 2012 - 2020 (USD Million)
3.2.4.Dental Market Implants Estimates and Forecasts, 2012 - 2020 (USD Million)
3.3. Surgical Instruments Market Estimates and Forecasts, 2012 - 2020 (USD Million)
3.4. Bioengineering Market Estimates and Forecasts, 2012 - 2020 (USD Million)

Chapter 4. Healthcare 3D Printing Technology Outlook
4.1. Electron Beam Melting Market Estimates and Forecasts, 2012 - 2020 (USD Million)
4.2. Laser Beam Melting Market Estimates and Forecasts, 2012 - 2020 (USD Million)
4.3. Photo-polymerization Market Estimates and Forecasts, 2012 - 2020 (USD Million)
4.3.1. Stereolithography
4.3.2. Digital light processing (DLP)
4.3.3. Two-Photon Polymerization (TPP)
4.4. Droplet Deposition Market Estimates and Forecasts, 2012 - 2020 (USD Million)
4.4.1. Inkjet Printing (IJP)
4.4.2. Fused Deposition Modeling (FDM)
4.4.3. Multiphase Jet Solidification (MJS)

Chapter 5. Healthcare 3D Printing Raw Material Outlook
5.1. Metals Market Estimates and Forecasts, 2012 - 2020 (USD Million)
5.2. Biological Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million)
5.3. Polymers Market Estimates and Forecasts, 2012 - 2020 (USD Million)
5.4. Ceramics Market Estimates and Forecasts, 2012 - 2020 (USD Million)

Chapter 6. Healthcare 3D Printing Regional Outlook
6.1. North America Healthcare 3D Printing Market
6.1.1. Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million)
6.1.2. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million)
6.1.3. Market Estimates and Forecasts, by Raw Materials, 2012 - 2020 (USD Million)
6.2. Europe Healthcare 3D Printing Market
6.2.1. Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million)
6.2.2. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million)
6.2.3. Market Estimates and Forecasts, by Raw Materials, 2012 - 2020 (USD Million)
6.3. Asia Pacific Healthcare 3D Printing Market
6.3.1. Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million)
6.3.2. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million)
6.3.3. Market Estimates and Forecasts, by Raw Materials, 2012 - 2020 (USD Million)
6.4. RoW Healthcare 3D Printing Market
6.4.1. Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million)
6.4.2. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million)
6.4.3. Market Estimates and Forecasts, by Raw Materials, 2012 - 2020 (USD Million)

Chapter 7. Competitive Landscape
7.1. 3D Systems Software
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Bio-Rad Laboratories
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. EnvisionTEC
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Materialise NV
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Stratasys Inc.
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Organovo
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. SOLS
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Simbionix
7.8.1. Company Overview
7.8.2. Financial Performance
7.3.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Metamason
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. RegenHU Ltd.
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives
7.11. Youbionic
7.11.1. Company Overview
7.11.2. Financial Performance
7.11.3. Product Benchmarking
7.11.4. Strategic Initiatives
7.12. Bio3D Technologies Pte Ltd
7.12.1. Company Overview
7.12.2. Financial Performance
7.12.3. Product Benchmarking
7.12.4. Strategic Initiatives
7.13. 3D Matters Pte Ltd.
7.13.1. Company Overview
7.13.2. Financial Performance
7.13.3. Product Benchmarking
7.13.4. Strategic Initiatives
7.14. 3D Systems Corporation (3DS)
7.14.1. Company Overview
7.14.2. Financial Performance
7.14.3. Product Benchmarking
7.14.4. Strategic Initiatives
7.15. Ekso Bionics
7.15.1. Company Overview
7.15.2. Financial Performance
7.15.3. Product Benchmarking
7.15.4. Strategic Initiatives
7.16. Roche Pharmaceuticals
7.16.1. Company Overview
7.16.2. Financial Performance
7.16.3. Product Benchmarking
7.16.4. Strategic Initiatives
7.17. Renishaw plc.
7.17.1. Company Overview
7.17.2. Financial Performance
7.17.3. Product Benchmarking
7.17.4. Strategic Initiatives
7.18. Robohand
7.18.1. Company Overview
7.18.2. Financial Performance
7.18.3. Product Benchmarking
7.18.4. Strategic Initiatives
7.19. Robohand
7.19.1. Company Overview
7.19.2. Financial Performance
7.19.3. Product Benchmarking
7.19.4. Strategic Initiatives
7.20. Delcam India
7.20.1 Company Overview
7.20.2 Financial Performance
7.20.3 Product Benchmarking
7.20.4 Strategic Initiatives
7.21. Worrell
7.21.1. Company Overview
7.21.2. Financial Performance
7.21.3. Product Benchmarking
7.21.4. Strategic Initiatives
7.22. MobileOCT
7.22.1. Company Overview
7.22.2. Financial Performance
7.22.3. Product Benchmarking
7.22.4. Strategic Initiatives
7.23. Rainbow Biosciences
7.23.1. Company Overview
7.23.2. Financial Performance
7.23.3. Product Benchmarking
7.23.4. Strategic Initiatives
7.24. ALD Vacuum Technologies
7.24.1. Company Overview
7.24.2. Financial Performance
7.24.3. Product Benchmarking
7.24.4. Strategic Initiatives
7.25. Arcam
7.25.1. Company Overview
7.25.2. Financial Performance
7.25.3. Product Benchmarking
7.25.4. Strategic Initiatives

Chapter 8. Methodology and Scope
8.1. Research Methodology
8.2. Research Scope & Assumption
8.3. List of Data Sources